Steliana Ghibu

6A Louis Pasteur Street
Cluj-napoca, CJ 400349, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Metabolic and Inflammatory Adverse Drug Reactions Associated with Amlodipine: A Descriptive and Disproportionality Analysis of EudraVigilance Reports.

Metabolic and Inflammatory Adverse Drug Reactions Associated with Amlodipine: A Descriptive and Disproportionality Analysis of EudraVigilance Reports.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 01, 2026

Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study.

Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 26, 2026

Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions-A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data.

Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions-A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 28, 2026

An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.

An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.

Journal: Pharmaceutics

Published: December 16, 2025

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database.

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 14, 2025

Osilodrostat Safety Profile: Findings from Real-World Data in the FAERS Database.

Osilodrostat Safety Profile: Findings from Real-World Data in the FAERS Database.

Journal: Journal of clinical medicine

Published: March 25, 2025

Bevacizumab-Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment.

Bevacizumab-Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 10, 2025

Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study.

Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study.

Journal: Journal of clinical medicine

Published: March 05, 2025

Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database.

Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database.

Journal: Cancers

Published: January 17, 2025

The Assessment of the Safety Profile of Selective Serotonin Reuptake Inhibitors Versus Other Antidepressants: Drug-Drug Interaction Insights from EudraVigilance.

The Assessment of the Safety Profile of Selective Serotonin Reuptake Inhibitors Versus Other Antidepressants: Drug-Drug Interaction Insights from EudraVigilance.

Journal: Journal of clinical medicine

Published: January 12, 2025

Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance.

Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 27, 2024

Safety Profiles Related to Dosing Errors of Rapid-Acting Insulin Analogs: A Comparative Analysis Using the EudraVigilance Database.

Safety Profiles Related to Dosing Errors of Rapid-Acting Insulin Analogs: A Comparative Analysis Using the EudraVigilance Database.

Journal: Biomedicines

Published: August 17, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026